BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $995 | -11.1% | 26,361 | +7.3% | 0.04% | -12.2% |
| Q2 2023 | $1,119 | +18.0% | 24,561 | +5.1% | 0.05% | +2.1% |
| Q1 2023 | $948 | -22.7% | 23,361 | -2.9% | 0.05% | -27.3% |
| Q4 2022 | $1,226 | -99.9% | 24,061 | -6.6% | 0.07% | -12.0% |
| Q3 2022 | $1,387,000 | -22.2% | 25,761 | -7.2% | 0.08% | -12.8% |
| Q2 2022 | $1,783,000 | -21.1% | 27,761 | -4.8% | 0.09% | +2.4% |
| Q1 2022 | $2,261,000 | -13.8% | 29,161 | -4.6% | 0.08% | -4.5% |
| Q4 2021 | $2,623,000 | -0.8% | 30,561 | -7.0% | 0.09% | -4.3% |
| Q3 2021 | $2,643,000 | -2.5% | 32,861 | -2.4% | 0.09% | -1.1% |
| Q2 2021 | $2,710,000 | -1.0% | 33,661 | +3.7% | 0.09% | -14.7% |
| Q1 2021 | $2,738,000 | +5.1% | 32,461 | 0.0% | 0.11% | -0.9% |
| Q4 2020 | $2,605,000 | -0.8% | 32,461 | -0.6% | 0.11% | -11.3% |
| Q3 2020 | $2,627,000 | -11.2% | 32,661 | -4.9% | 0.12% | -11.4% |
| Q2 2020 | $2,958,000 | +13.3% | 34,361 | +6.8% | 0.14% | -11.4% |
| Q1 2020 | $2,611,000 | -14.6% | 32,161 | -12.0% | 0.16% | +23.4% |
| Q4 2019 | $3,057,000 | -4.4% | 36,561 | 0.0% | 0.13% | -11.7% |
| Q3 2019 | $3,198,000 | -0.0% | 36,561 | -6.4% | 0.14% | +4.3% |
| Q2 2019 | $3,199,000 | -4.6% | 39,061 | -5.3% | 0.14% | -3.5% |
| Q1 2019 | $3,355,000 | +20.6% | 41,261 | -2.4% | 0.14% | +9.1% |
| Q4 2018 | $2,782,000 | -17.9% | 42,261 | -3.9% | 0.13% | +2.3% |
| Q3 2018 | $3,389,000 | +0.1% | 43,961 | -4.1% | 0.13% | -3.0% |
| Q2 2018 | $3,386,000 | +9.0% | 45,861 | -4.0% | 0.13% | +12.7% |
| Q1 2018 | $3,106,000 | -0.2% | 47,761 | -0.8% | 0.12% | 0.0% |
| Q4 2017 | $3,113,000 | +9.4% | 48,161 | +6.2% | 0.12% | -13.2% |
| Q3 2017 | $2,846,000 | +3.8% | 45,361 | 0.0% | 0.14% | +2.3% |
| Q2 2017 | $2,743,000 | +7.4% | 45,361 | -7.9% | 0.13% | +11.8% |
| Q1 2017 | $2,555,000 | +3.1% | 49,261 | -11.8% | 0.12% | +3.5% |
| Q4 2016 | $2,477,000 | -6.8% | 55,861 | 0.0% | 0.12% | -13.5% |
| Q3 2016 | $2,659,000 | -8.6% | 55,861 | -13.2% | 0.13% | +1.5% |
| Q2 2016 | $2,910,000 | +17.0% | 64,361 | +6.3% | 0.13% | +10.1% |
| Q1 2016 | $2,487,000 | -41.8% | 60,552 | -49.8% | 0.12% | +15.5% |
| Q4 2015 | $4,275,000 | +112.2% | 120,604 | +96.6% | 0.10% | +4.0% |
| Q3 2015 | $2,015,000 | -49.8% | 61,352 | +7.0% | 0.10% | -49.2% |
| Q2 2015 | $4,011,000 | -7.0% | 57,352 | -8.9% | 0.20% | +3.2% |
| Q1 2015 | $4,312,000 | -10.2% | 62,952 | -4.0% | 0.19% | -7.4% |
| Q4 2014 | $4,804,000 | -7.6% | 65,552 | -9.5% | 0.20% | -3.3% |
| Q3 2014 | $5,200,000 | +1.4% | 72,452 | +2.1% | 0.21% | 0.0% |
| Q2 2014 | $5,130,000 | -1.7% | 70,952 | 0.0% | 0.21% | -4.1% |
| Q1 2014 | $5,221,000 | – | 70,952 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |